CYSLTR1 is predominantly expressed in airway smooth muscle cells, mast cells, eosinophils, monocytes, and macrophages, mediating chronic airway inflammation and tissue damage through bronchoconstriction, increased vascular permeability, and inflammatory cell infiltration (Trinh et al., 2019). The gene discussed is CYSLTR1; the disease is inflammatory response.